Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2.02	42.99	42.14
Graham Fair Price	62.07	77.49	47.81
PEG	-85.55	0.19	-1.30
Price/Book	20.51	12.42	10.31
Price/Cash Flow	-7.44	124.22	134.21
Prices/Earnings	-49.71	28.45	56.58
Price/Sales	17.75	28.29	24.03
Price/FCF	-7.44	124.22	134.21
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	17.63	0.47	0.40
Operating Margin	66.36	0.28	0.17
ROA	148.19	0.05	0.02
ROE	0.05	0.11	139.63
ROIC	0.03	0.07	89.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	0.02	696.84
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.22	0.77	249.72
EPS QOQ	-0.43	1.51	248.13
FCF QOQ	-0.16	0.35	116.04
Revenue QOQ	0.03	0.06	82.29
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6.93	-572.52	8156.24
Days Sales Outstanding (DSO)	18.77	11.79	-37.20
Inventory Turnover	12.98	-0.16	-98.79
Debt/Capitalization	0.41	0.40	-2.68
Quick Ratio	1.01	0.89	-12.09
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	47.23	49.45	4.70
Cash	16.37	16.31	-0.39
Capex	-0.19	-0.18	6.43
Free Cash Flow	3.63	4.95	36.32
Revenue	20.26	21.71	7.16
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.12	1.07	-4.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.42	1.53	7.08
Naive Interpretation	Member

06 - Financial Health · Bad

Rating